News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Selcia Limited Celebrates The Success Of A Recent Medicines and Healthcare Products Regulatory Agency Inspection Of Its GMP Radiolabelling Facility


11/25/2013 11:57:58 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Ongar, UK. 25 November 2013. Selcia Limited, the international life sciences CRO, has announced a successful inspection of its GMP radiochemistry facility by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA). This has resulted in the granting of a new Good Manufacturing Practice (GMP) certificate for the preparation and 14C labelling of Active Pharmaceutical Ingredients (APIs).

Commenting, Selcia’s CEO, Dr Hans Fliri said: “The preparation of 14C-APIs under GMP continues to be a strong offering from Selcia to our customers who require material suitable for use in clinical trials. Selcia has again demonstrated the impressive quality of its radiolabelling services”.

Director of Radiochemistry Dr Gill Little said: “The certification of our GMP 14C-API facility is confirmation of the world class standards attained by Selcia’s hard-working dedicated radiochemistry and QC teams who successfully deliver many GMP and non-GMP 14C-radiosynthesis projects every year”.

About Selcia

Selcia is a privately held company providing both 14C radiolabelling and integrated drug discovery services, operating from a modern facility in Ongar, Essex, UK.

Selcia’s radiolabelling division produces C-14 radiolabelled compounds for a global customer base encompassing both the life sciences and chemical industries. Applications of the radiolabelled products prepared by Selcia include: preclinical and clinical drug metabolism studies; mass balance, microdosing, research and regulatory studies; and environmental fate studies.

Selcia’s analytical laboratory is a member of the UK GLP Compliance Monitoring Programme.

KEY CONTACTS:

Media contact

Andy Matthews

+44 (0)7967 153753

andy.matthews@o2pr.co.uk

For further details about Selcia’s Radiolabelling service please contact

Dave Roberts

+44 (0)1277 367000

contact@selcia.com

Andy Matthews

Director

O2PR LTD

Tel: +44 (0)1223 309500

Mob: +44 (0)7967 153753

E: andy.matthews@o2pr.co.uk

W: www.o2pr.co.uk

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES